Coulter Partners' top hires for VC & PE portfolio companies Q3-2023

This quarter’s successful placements include:

FunctionFocus areaLocation
CEOMedical equipmentFrance
CEO (US-based)CAR-T therapiesUK
Chief Product OfficerEHR data platformSpain
Chief Scientific OfficertRNA-based therapeuticsUS
Chief Financial OfficerR&D consulting servicesUS
Group Chief Financial OfficerOutpatient services (aesthetic medicine)Switzerland
Chief Business Officer (US-based)AI for drug discoveryCentral & Eastern Europe
Head of Business Development, North AmericaContract research organisationCanada
VP Clinical AffairsAnalgesic productsUS
VP OperationsBio-electrical implantable devicesUK
VP Global Program Lead (US-based)Multi-modality biotechUK
Country Regional DirectorVeterinary servicesNordics
ChairProtein therapeuticsUK
Board DirectorOncology drug discoveryGermany

Newly opened projects include:

FunctionFocus areaLocation
CEOMedical devicesIsrael
CEOOutpatient servicesGermany
Country CEOHealthcare servicesSweden
Chief Strategy OfficerEndoscopic devicesIsrael
Chief Product OfficerMedical information servicesUK
Chief Medical OfficerSmall moleculesItaly
Head of Drug Metabolism & PharmacokineticsCNS platform technologyUK
Head of TechOpsRadiopharmaceuticalsChina
VP Business DevelopmentTransplant technologyUS
VP SalesDigital pathology solutionsFrance
Managing DirectorPrivate equity investorUS
Head of Alliance ManagementLife sciences incubatorUK
General Manager Infectious DiseasesBioclusterFrance
ChairDigital therapeutics/ devicesUS
Board DirectorPrecision contract manufacturingUS